Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Meta Stock Jumps as AI Cloud Expansion Challenges AWS, Microsoft, and Google
Super Micro Employees Detained in Taiwan AI Server Export Investigation
Morgan Stanley Names BAE Systems Top European Defence Stock Despite Lower Price Target
Samsung to Invest $90 Billion in South Korea to Expand AI Chip, Display, and Battery Production
Anthropic Brings Claude AI Models to Microsoft Azure Foundry With NVIDIA Blackwell GPUs
Apple Expands iPhone Lineup, Boosts Foldable iPhone Production Plans Through 2027
ShareChat Eyes 2027 IPO After Reaching Operational Profitability, Report Says
TSMC CoWoS Capacity Forecast Raised as Mizuho Sees AI Server CPU Demand Surging Through 2027
South Korea Alleges Google Abused Android App Store Dominance, Eyes Major Fine
Microsoft Reportedly Plans New Job Cuts Across Sales, Consulting, and Xbox
SK Holdings, KKR Launch $1.3B Renewable Energy Venture in South Korea
South32 Sells Major Aluminium Assets to Alcoa in Deal Worth Up to $5.6 Billion
Buffett Delays Gates Foundation Donation Pending Epstein Ties Review
OpenAI Proposes 5% U.S. Government Stake Amid AI Policy Talks
Trump Reports $1.4 Billion in Crypto Income as Digital Assets Become Top Wealth Source
EU Chip Industry Faces Growing Risks From China Export Controls and U.S. Technology Dependence: Report
Trump Administration to Launch Voluntary AI Standards for Frontier Models 



